Albemarle (ALB) Price Target Cut to $150.00 by Analysts at Jefferies Group

Albemarle (NYSE:ALB) had its price target cut by research analysts at Jefferies Group to $150.00 in a report issued on Friday, January 19th. The brokerage presently has a “buy” rating on the specialty chemicals company’s stock. Jefferies Group’s price target suggests a potential upside of 34.42% from the stock’s previous close.

A number of other research firms also recently issued reports on ALB. Loop Capital initiated coverage on Albemarle in a research note on Thursday, September 28th. They issued a “buy” rating and a $150.00 price objective on the stock. Royal Bank of Canada reaffirmed a “buy” rating and issued a $149.00 price objective on shares of Albemarle in a research note on Wednesday, October 18th. Nomura lifted their target price on Albemarle from $146.00 to $154.00 and gave the stock a “buy” rating in a report on Tuesday, October 10th. Robert W. Baird reiterated a “hold” rating and issued a $135.00 target price on shares of Albemarle in a report on Wednesday, November 1st. Finally, Oppenheimer lifted their target price on Albemarle from $133.00 to $157.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. Ten investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Albemarle presently has a consensus rating of “Buy” and a consensus price target of $127.88.

Shares of Albemarle (ALB) traded up $3.87 on Friday, reaching $111.59. The company had a trading volume of 2,640,000 shares, compared to its average volume of 2,270,000. The company has a market cap of $12,330.00, a P/E ratio of 39.85, a PEG ratio of 1.42 and a beta of 1.56. Albemarle has a 52 week low of $90.35 and a 52 week high of $144.99. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56.

Several hedge funds have recently modified their holdings of the business. ARK Investment Management LLC lifted its holdings in shares of Albemarle by 40.0% in the 4th quarter. ARK Investment Management LLC now owns 8,333 shares of the specialty chemicals company’s stock worth $1,066,000 after buying an additional 2,380 shares during the period. Quadrature Capital Ltd bought a new position in shares of Albemarle in the 4th quarter worth $508,000. Allen Capital Group LLC bought a new position in shares of Albemarle in the 4th quarter worth $604,000. Suntrust Banks Inc. raised its position in shares of Albemarle by 8.4% in the 4th quarter. Suntrust Banks Inc. now owns 17,920 shares of the specialty chemicals company’s stock worth $2,290,000 after acquiring an additional 1,389 shares in the last quarter. Finally, Stanley Laman Group Ltd. bought a new position in shares of Albemarle in the 4th quarter worth $729,000. Institutional investors and hedge funds own 87.38% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.thelincolnianonline.com/2018/02/12/jefferies-group-lowers-albemarle-alb-price-target-to-150-00-updated-updated-updated.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply